Contrast-Induced Nephropathy and Long-Term Adverse Events
Open Access
- 1 July 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 4 (7), 1162-1169
- https://doi.org/10.2215/cjn.00550109
Abstract
Background and objectives: The relationship of contrast-induced nephropathy (CIN) to long-term adverse events (AEs) is controversial. Although an association with AEs has been previously reported, it is unclear whether CIN is causally related to these AEs. Design, setting, participants, & measurements: We obtained long-term (≥1 yr) follow-up on 294 patients who participated in a randomized, double-blind comparison of two prevention strategies for CIN (iopamidol versus iodixanol). A difference in the incidence of AEs between patients who had developed CIN and those who had not was performed using a χ2 test and Poisson regression analysis. A similar statistical approach was used for the differences in AEs between those who received iopamidol or iodixanol. Multiple definitions of CIN were used to strengthen and validate the results and conclusions. Results: The rate of long-term AEs was higher in individuals with CIN (all definitions of CIN). After adjustment for baseline comorbidities and risk factors, the adjusted incidence rate ratio for AEs was twice as high in those with CIN. Randomization to iopamidol reduced both the incidence of CIN and AEs. Conclusions: The parallel decrease in the incidence of CIN and AEs in one arm of this randomized trial supports a causal role for CIN.Keywords
This publication has 17 references indexed in Scilit:
- Renal failure after percutaneous coronary intervention is associated with high mortalityCatheterization and Cardiovascular Interventions, 2005
- Contrast-Induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variablesThe American Journal of Cardiology, 2005
- Chronic Kidney Disease Awareness, Prevalence, and Trends among U.S. Adults, 1999 to 2000Journal of the American Society of Nephrology, 2005
- Early detection of acute renal failure by serum cystatin CKidney International, 2004
- Fenoldopam Mesylate for the Prevention of Contrast-Induced NephropathyJAMA, 2003
- The Prevention of Radiocontrast-Agent–Induced Nephropathy by HemofiltrationNew England Journal of Medicine, 2003
- Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysisAmerican Journal of Kidney Diseases, 2002
- Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary InterventionCirculation, 2002
- The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiencyJournal of the American College of Cardiology, 2000
- Acute Renal Failure After Coronary InterventionAmerican Journal Of Medicine, 1997